Amafutha we-Cod kwesibindi uhlobo lwamafutha enhlanzi atholakalayo efomini le-capsule. Ukuhlwithwa esibindi sesinhlanzi se-cod, amafutha anesithambile A, vitamin D, nama-omega-3 fatty acids. Ngenxa yokuqukethwe kwayo ephezulu ye-omega-3, i-cod i-ovali-3 isetshenziswa ngama-brand amaningi wemvelo.
Ukusebenzisa i-Cod Oil Oil
Ngama-1800, amafutha e-cod isibindi asithandwa njengendlela yokondla yokudla yezingane ezingenalo ukukhanya kwelanga ukukhulisa ingozi yazo yezifo (isifo esibangelwa ukutholakala kwevithamini D).
Namuhla, abanye abaxhasi bezokwelapha abathile bathi amafutha e-cod esibindi angasiza ngemibandela eminingi yezempilo, kuhlanganise:
- Ukucindezeleka
- Isifo sikashukela
- I-glaucoma
- Isifo senhliziyo
- Umfutho wegazi ophezulu
- I-cholesterol ephakeme
- Lupus
- I-osteoarthritis
Izinzuzo zezempilo ze-Cod Oil Oil
Ngokusho kwamaNational Institutes of Health (NIH), amafutha enhlanzi cishe ayasebenza ekuvimbeleni isifo senhliziyo. Ngaphezu kwalokho, i-NIH ithi amafutha okudoba angasiza ekunciphiseni ukucindezeleka kwegazi kanye ne-cholesterol, ukuphatha i- asthma ne- rheumatoid arthritis , ukunciphisa ubuhlungu bokuya esikhathini , ukunciphisa ingozi yokushaya isisu , ukuvikela ukulwa nesifo se- osteoporosis nokunciphisa ukuqhubeka kwe- atherosclerosis . Kodwa-ke, i-NIH ayicacisi ukuthi ngabe i-cod yamafutha esibindi ikakhulukazi (kunokuba inhlanzi yamafutha ehlongozwe kwezinye izinhlobo zezinhlanzi) ingase ivelise lezi zinzuzo zezempilo.
Nakuba ucwaningo ngemiphumela ethize yezempilo ye-cod yamafutha e-foy is a limited, izifundo ezithile zibonisa ukuthi amafutha e-cod isibindi angasiza ngezimo ezilandelayo:
1) Izifo Eziphefumulayo Eziphezulu Zokuphefumula
Amafutha e-Cod kwesibindi angasiza ekuvimbeleni izifo ezithathelwanayo zokuphefumula, ngokwesifundo se-2004 sezingane ezingu-94. Ishicilelwe kuyi- Annals of Otology, i-Rhinology ne-Laryngology , isifundo sathola ukuthi abahlanganyeli abathola amafutha e-cod kanye ne-multivitamin-amaminerali nsuku zonke kusukela ekwindla ngasekupheleni kwentwasahlobo babhekana nokwehliswa okukhulu kwenani lezinkinga zokuphefumula ezingaphezulu (ezifana umkhuhlane ovamile ).
2) Isifo sikashukela
Ukuthatha amafutha e-cod ngesikhathi sokukhulelwa kunganciphisa ingozi yengane yesifo sikashukela sohlobo 1, kubonisa umbiko we-2000 ovela encwadini ethi Diabetologia . Ukuhlaziya idatha kumama angama-85 anesifo sikashukela nabesifazane abakhulelwe abangu-1,071 abanesifo sikashukela, abalobi bezocwaningo bathola ingozi ephezulu kakhulu yesifo sikashukela phakathi kwabantwana abazalelwa kubahlanganyeli ababedlile amafutha ekhukhukazi ngenkathi bekhulelwe.
Ngaphezu kwalokho, isifundo se-2003 sabantu abangu-2,213 (eshicilelwe kuyi- American Journal of Clinical Nutrition ) sathola ukuthi ukuthatha amafutha e-cod isibindi ngonyaka wokuqala wokuphila kwakuhlanganiswe nengozi encane yokwehla kwesifo sikashukela sohlobo lwe-1.
3) I-Arthritis
Kubantu abane-arthritis ye-rheumatoid, ukuthatha amafutha e-cod kwesibindi kunganciphisa isidingo semithi engeyona-steroidal anti-inflammatory (NSAIDs). Ukuze kuqhutshwe ucwaningo olwenziwe ngo-2008 eRheumatology , abacwaningi banikeze iziguli ezingama-97 zesifo se-rheumatoid arthritis kuya ezinyangeni eziyisishiyagalolunye zokwelashwa nge-cod amafutha esibindi noma i-placebo. Ukubuka idatha kubantu abangu-58 abaqedile ukutadisha, bathole ukuthi amaphesenti angu-39 eqembu lamafutha e-cod likwazi ukunciphisa ukungenisa kwabo kwe-NSAID nsuku zonke ngamaphesenti angaba ngu-30 (uma kuqhathaniswa namaphesenti angu-10 esigabeni se-placebo).
Esifundweni esasuka ku-Advances in Therapy , ososayensi bathola ukuthi ukuthatha amafutha e-cod isibindi kungasiza ekunciphiseni ukuqina, ubuhlungu nokuvuvukala kubantu abane-arthritis ye-rheumatoid.
Amafutha we-Cod kwesibindi iyisiluleko esisodwa se-arthritis ye-rheumatoid.
Amafutha we-Cod Liver vs. Amafutha Ezinhlanzi
Njengoba kucatshangwa ukuthi ezinye izinhlobo ze-cod zengozini, ukuthola ama-omega-3 akho kwezinye izinhlobo zamafutha ezinhlanzi (njenge-saumon) angase abe nempilo eningi. Uma ungumvuno, ungathola ama-acids e-omega-3 emithonjeni yemifino efana ne- flaxseed .
Kuyini i-Fermented Oil Cod Liver?
Abagqugquzeli bamafutha omzimba we-cod ovuthayo bathi lolu hlobo lwamafutha we-cod lobisi luhlanzekile futhi lukhudlwana ku-vitamin A, i-vitamin D nama-omega-3 amafutha acids kunamafomu okusetshenziselwa ukushisa kwamafutha e-cod. Noma kunjalo, okwamanje kuntuleka kobufakazi besayensi ukusekela lesi simangalo.
Amapulangwe
Amafutha wezinhlanzi angabangela imiphumela emibi (kubandakanya ukuphefumula okubi , ukushaya inhliziyo, isicashu, kanye nokubamba).
Uma kusetshenziswe ngokweqile, amafutha e-cod isibindi angaholela kumazinga anobuthi amavithamini A kanye no-D. I-Cod yamafutha e-fox ingaqukatha ezinye izinto ezingadingeki njengezinsimbi ezisindayo nama-PCB. Ukwengeza, ukuphakama okukhulu kwamafutha enhlanzi kungavimbela ukugaya igazi, ukulimaza amasosha omzimba nokukhulisa amazinga egazi le-LDL ("bad").
Uma ucabangela ukusebenzisa i-cod yamafutha esibindi ngokuhlanganiswa nezinye izithako noma imithi, khuluma nodokotela wakho ngaphambi kokuqala ukwelashwa. Kubalulekile ukuqaphela ukuthi ukugwema ukwelashwa okujwayelekile kanye nokwelapha isimo esingapheliyo ngamafutha we-cod (noma noma yiluphi olunye uhlobo lwemithi ehlukile) kungase kube nemiphumela emibi yempilo.
Imithombo
I-American Cancer Society. "Omega-3 Fatty Acids". Novemba 2008.
Galarraga B, Ho M, Youssef HM, Hill A, McMahon H, Hall C, Ogston S, Nuki G, Belch JJ. "I-Cod yamafutha we-cod (i-n-3 fatty acids) njenge-agent engeyona i-steroidal yokuvimbela izidakamizwa zokulwa nezidakamizwa ku-arthritis ye-rheumatoid." I-Rheumatology (i-Oxford). 2008 Meyi; 47 (5): 665-9.
I-Gruenwald J, i-Graubaum HJ, i-Harde A. "Imiphumela yeoli ye-cod ye-food yezimpawu zesifo samathambo esifubeni se-rheumatoid." U-Adv Ther. 2002 Mar-Apr; 19 (2): 101-7.
Linday LA, Shindledecker RD, Tapia-Mendoza J, Dolitsky JN. "Umphumela wamafutha we-cod yansuku zonke kanye ne-multivitamin-mineral supplement ne-selenium ekuhambeni okuphezulu okuphefumulela ukuvakasha kwezingane ezincane, ezingaphakathi-dolobha, ezinganeni zaseLatinino: amasayithi omntwana angahleliwe." I-Ann Otol Rhinol Laryngol. 2004 Nov; 113 (11): 891-901.
Izikhungo zezempilo zikazwelonke. "Amafutha wezinhlanzi: Ama-supplement MedlinePlus". Agasti 2011.
I-Stene LC, i-Joner G; I-Norwegian Childhood Diabetes Study Group. "Ukusetshenziswa kwamafutha e-cod isibindi phakathi nonyaka wokuqala wokuphila kuhlotshaniswa nengozi ephansi yokushukela kwesifo sikashukela sohlobo lwezingane 1: isifundo esikhulu sokulawula abantu, esilandelayo." I-Am J Clin Nutr. 2003 Dec; 78 (6): 1128-34.
Stene LC, Ulriksen J, Magnus P, Joner G. "Ukusetshenziswa kwamafutha e-cod kwesibindi ngesikhathi sokukhulelwa kuhlotshaniswa nobungozi obuncane bokuthi i-Type I isifo sikashukela kule nzalo." I-Diabetologia. 2000 Sep; 43 (9): 1093-8.
Ukuziphendulela: Ulwazi oluqukethwe kule sayithi luhloswe ngezinjongo zemfundo kuphela futhi aluthathi iseluleko, ukuxilongwa noma ukwelashwa ngudokotela olayisensi. Akuhloselwe ukumboza zonke izinyathelo zokuqapha, ukusebenzisana kwezidakamizwa, izimo noma imiphumela emibi. Kufanele ufune ukunakekelwa okusheshayo kwezokwelapha kunoma yiziphi izinkinga zezempilo bese uthintana nodokotela wakho ngaphambi kokusebenzisa enye imithi noma wenze ushintsho ohlelweni lwakho.